DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 177 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 3.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,496,000 | -46.2% | 74,186 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $2,783,000 | +95.2% | 74,186 | +33.0% | 0.00% | +50.0% |
| Q1 2021 | $1,426,000 | -1.7% | 55,786 | -15.3% | 0.00% | 0.0% |
| Q4 2020 | $1,451,000 | +22.4% | 65,880 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,185,000 | -29.2% | 65,880 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,673,000 | +42.1% | 65,880 | +2.8% | 0.00% | 0.0% |
| Q1 2020 | $1,177,000 | -27.1% | 64,080 | -12.6% | 0.00% | 0.0% |
| Q4 2019 | $1,614,000 | +104.3% | 73,280 | +33.3% | 0.00% | +100.0% |
| Q3 2019 | $790,000 | -6.2% | 54,980 | +2.8% | 0.00% | 0.0% |
| Q2 2019 | $842,000 | +55.4% | 53,480 | +44.6% | 0.00% | 0.0% |
| Q1 2019 | $542,000 | +220.7% | 36,980 | +134.1% | 0.00% | – |
| Q4 2018 | $169,000 | – | 15,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 2,005,238 | $16,463,000 | 5.12% |
| Abingworth LLP | 945,757 | $7,755,000 | 4.53% |
| RA Capital Management | 2,428,571 | $19,939,000 | 2.86% |
| Omega Fund Management, LLC | 223,457 | $1,835,000 | 1.03% |
| DAFNA Capital Management LLC | 123,500 | $1,014,000 | 1.01% |
| Iguana Healthcare Management, LLC | 100,000 | $821,000 | 0.32% |
| Cormorant Asset Management, LP | 245,000 | $2,011,000 | 0.32% |
| Eventide Asset Management | 315,300 | $2,589,000 | 0.15% |
| AWM Investment Company, Inc. | 80,000 | $657,000 | 0.13% |
| Palo Alto Investors LP | 267,890 | $2,199,000 | 0.11% |